Profile

William H. Hinson, Ph.D.Wake Forest School of Medicine

William H. Hinson, Ph.D.

Associate Professor,

Clinical Interests

Radiation Oncology Physics, Magnetic Resonance Imaging, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery

Contact Information

Academic: 336-713-6521 | Department: 336-713-3600

Email: whinson@wakehealth.edu

Education & Training

  • B.A., Wake Forest University , 1983
  • M.S., Wake Forest University , 1985
  • Ph.D., Wake Forest University , 1999

Memberships

  • Am Assn Of Physicists In Med
  • Am Soc Ther Rad & Rad Oncology
William H. Hinson, Ph.D.

William H. Hinson, Ph.D.

Associate Professor, Radiation Oncology

Contact Information

Academic: 336-713-6521 | Department: 336-713-3600

Email: whinson@wakehealth.edu

Recent Publications

Kilburn JM, Lester SC, Lucas JT Jr, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer. J Thorac Oncol. 2014;9(4):572-576.

Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014;110(3):505-510.

Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014;37(2):177-181.

Leyrer CM, Chan MD, Peiffer AM, Horne E, Harmon M, Carter AF, Hinson WH, Mirlohi S, Duncan SE, Dietrich AM, Lesser GJ. Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol. 2014;4(2):130-135.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.

Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock D, Kuremsy JG, Blackstock A, Hinson WH, Miller AA, Petty WJ, Munley MT. Which lung tumors shrink during fractionated radiation and how does this influence outcome?: Appropriately selecting tumor and treatment characteristics for adaptive radiation therapy protocols [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S641-S642.

Lester SC, Kilburn JM, Lucas JT, Soike MH, Blackstock AW, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. An evaluation of toxicity using accumulated total dose based on EQD2 for thoracic reirradiation incorporating at least 1 course of SBRT [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S640-S641.

Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD. Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD. Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747-753.

Ayala-Peacock DN, Blackstock AW, Kearns WT, Hinson WH, Munley MT, Miller AA, Petty WJ, Urbanic JJ. Stereotactic body radiation therapy (SBRT) and image guided accelerated hypofractionated radiation therapy (IGAHRT) for the treatment of oligometastatic cancers [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S567-S568.

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock D, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Is a clinical target volume (CTV) necessary in treatment of thoracic malignancies treated in the modern era combining 4-D imaging and image guided radiation therapy (IGRT)? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S549.

Kilburn JM, Lester SC, Lucas JT, Blackstock AW, Kearns WT, Hinson WH, Munley MT, Miller AA, Petty WJ, Urbanic JJ. Multiple courses of thoracic radiation therapy (XRT) using stereotactic body radiation therapy (SBRT) as the first or second course of treatment for tumors outside the original high-dose region [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S36.

Lester SC, Kilburn JM, Lucas JT, Munley MT, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Salvage radiation for mediastinal relapse after treatment with accelerated hypofractionated radiation therapy (AHRT) or stereotactic body radiation therapy (SBRT) for stage I/II NSCLC [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S543-S544.

Soike M, Kilburn JM, Lucas JT, Ayala-Peacock D, Blackstock AW, Kearns WT, Hinson WH, Miller AT [sic] [Miller AA], Petty WJ, Urbanic JJ. Image guided radiation therapy results in mproved local control in lung cancer patients treated with fractionated radiation therapy for stage IIB-IIIB disease [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S547-S548.

Peiffer AM, Burke A, Leyer CM, Shing E, Kearns WT, Hinson WH, Case D, Rapp SR, Shaw EG, Chan MD. Normal tissue complication probability (Ntcp) model of radiation-induced mood disruption [abstract]. Neuro Oncol. 2013;15(Suppl 3):230.

Kilburn JM, Kuremsky JG, Blackstock AW, Kearns WT, Hampton CJ, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Thoracic reirradiation in patients with stereotactic body radiation therapy (SBRT) as first or second course of treatment [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S604.

Kuremsky JG, Petty WJ, Miller A, Hinson WH, Hampton CJ, Blackstock AW, Urbanic JJ. Hypofractionated radiation therapy for stage I and II non-small cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S153-S154.

Leyrer M, Chan MD, Peiffer AM, Horne E, Harmon M, Carter AF, Hinson WH, Duncan SE, Dietrich AM, Lesser GJ. Radiation-induced taste and smell toxicity: a dose-volume histogram analysis of a prospective observational study [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S302.

Paulsson A, Peiffer AM, McMullen KP, Hinson WH, Lesser GJ, Ellis TL [deceased], Tatter SB, Shaw EG, Chan MD. Comparison of clinical outcomes for single focus and multifocal glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S274.

Urbanic JJ, Soike M, Hampton CJ, Lucas J, Hinson W, Kearns W, Blackstock AW. Long-term follow-up and patterns of failure for patients with medically inoperable stage I non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S609.

Kilburn KM, Kuremsky JG, Blackstock AW, Kearns WT, Hampton CJ, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation in patients with stereotactic body radiotherapy (SBRT) as first or second course of treatment [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S253-S254.

Kuremsky JG, Petty WJ, Miller A, HInson WH, Hampton CJ, Blackstock AW, Urbanic JJ. Hypofractionated radiotherapy for stage I and II non-small cell lung cancer [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S230.

Lucas JT, Kuremsky JG, Soike M, Hinson W, Kearns WT, Hampton CJ, Blackstock AW, Urbanic JJ. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for stage 1 & 2 non-small cell lung cancer (NSCLC) [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S228.

Urbanic JJ, Soike M, Hampton CJ, Lucas J, Hinson W, Kearns W, Blackstock AW. Long-term follow-up and patterns of failure for patients with medically inoperable Stage I non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) [abstract]. J Thorac Oncol. 2012;7(9 suppl 4):S288.

Leyrer CM, Peiffer AM, Greene-Schloesser DM, Kearns WT, Hinson WH, Tatter SB, Rapp SR, Robbins ME, Shaw EG, Chan MD. Normal tissue complication modeling of the brain: dose-volume histogram analysis of neurocognitive outcomes of two CCOP trials [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S184-S185.

Paulsson AK, Chan MD, Peiffer AM, Hinson WH, Kearns WT, Lesser GJ, Ellis TL, Tatter SB, Shaw EG, McMullen KP. Decreased CTV margin size does not affect patterns of failure for glioblastoma treated with concurrent radiotherapy and temozolomide [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S183.

Peiffer AM, Leyrer CM, Greene-Schloesser D, Kearns WT, Hinson WH, Tatter SB, Rapp SR, Robbins ME, Shaw EG, Chan MD. Normal tissue complication modeling of the brain: dose-volume histogram analysis of neurocognitive outcomes of two CCOP trials [abstract]. Neuro Oncol. 2011;13(Suppl 3):73.

Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J [sic] [Cappellari J], Oaks T, Miller AA, Blackstock AW. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer. J Thorac Oncol. 2010;5(1):69-74.

Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078-4101.

Hinson WH, Kearns WT, deGuzman AF, Bourland JD. Photon spectral characteristics of dissimilar 6 MV linear accelerators. Med Phys. 2008;35(5):1698-1702.

Benedict SH, Bova FJ, Clark B, Goetsch SJ, Hinson WH, Leavitt DD, Schlesinger DJ, Yenice KM. Anniversary paper: the role of medical physicists in developing stereotactic radiosurgery. Med Phys. 2008;35(9):4262-4277.

Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH. Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): volumetric analysis [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S617.

Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH. Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): dosimetric analysis [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S625-S626.

Kearns WT, Urbanic JJ, Hampton CJ, McMullen KP, Blackstock AW, Stieber VW, Hinson WH. Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy. J Appl Clin Med Phys. 2008;9(3):141-146.

Urbanic JJ, McMullen KP, Stieber VW, Hinson WH, Kearns WT, Hampton CJ, Lovato JF, Livengood K, Rosdahl R, Blackstock AW. A phase I/II dose-escalation/efficacy study, of single fraction stereotactic body radiotherapy (SF-SBRT) for metastatic cancer [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S140.

Ekstrand KE, Hinson WH, Kearns W, Bourland JD, deGuzman AF, McMullen KP, Stieber VW. Optically guided linac radiosurgery with a Leksell head frame as an adjunct to gamma knife treatment. Technol Cancer Res Treat. 2007;6(2):123-126.

Hinson WH, Kearns WT, Ellis TL, Sprinkle D, Cullen T, Smith PG, Stieber VW. Reducing set-up uncertainty in the Elekta Stereotactic Body Frame using Stealthstation software. Technol Cancer Res Treat. 2007;6(3):181-186.

Ekstrand K, Munley M, Kearns W, Hinson W, deGuzman A. Light-radiation field coincidence for small stereotactic fields [abstract]. Med Phys. 2007;34(6):2466.

Hampton CJ, Kearns WT, Hinson WH. New tools and methodology for stereotactic body radiotherapy (SBRT) simulation using 4DCT [abstract]. Med Phys. 2007;34(6):2474.

Hinson WH, Kearns WT, deGuzman AF, Bourland JD. Photon spectral characteristics of dissimilar 6MV linear accelerators [abstract]. Med Phys. 2007;34(6):2481.

Hinson WH, Kearns WT, Hampton CJ, Urbanic JJ, Blackstock AW, McMullen KP, Stieber VW. SBRT simulations using PET/CT: radiation safety concerns [abstract]. Med Phys. 2007;34(6):2488.

Kearns WT, Bourland JD, Hinson WH, Hampton CJ, Munley MT. Implementation and special considerations for dedicated PET/CT simulation in radiation oncology [abstract]. Med Phys. 2007;34(6):2398.

Kearns WT, Hinson WH, Hampton CJ, Butler JM, Urbanic JJ, Starnes D, deGuzman AF, Stieber VW. Radiation safety issues with PET/CT simulation for stereotactic body radiotherapy [abstract]. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S712-S713.

Urbanic JJ, Hinson WH, Stieber VW, Butler JM, Kearns WT, Hampton CJ, Blackstock AW. Heterogeneity corrections in stereotactic body radiotherapy (54 Gy in 3 fractions) for lung tumors significantly alter delivered dose [abstract]. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S479-S480.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Radiation Oncology

Clinical Interests

Radiation Oncology Physics, Magnetic Resonance Imaging, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery
William H. Hinson, Ph.D.

William H. Hinson, Ph.D.

Associate Professor, Radiation Oncology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.